Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis

Journal of Experimental Medicine

Volumn 189, Issue 12, 1999, Pages 1863-1873

  Wilkinson, Robert J ^a,b   Patel, Punita ^b   Llewelyn, Martin ^b   Hirsch, Christina S ^a   Pasvol, Geoffrey ^b   Snounou, Georges ^b   Davidson, Robert N ^b   Toossi, Zahra ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Disease; Granuloma; Hypersensitivity delayed; Interleukin 1 receptor; Susceptibility; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RNA SYNTHESIS; TUBERCULOSIS; TUBERCULOUS PLEURISY;

CELL DIVISION; GENOTYPE; HAPLOTYPES; HUMANS; HYPERSENSITIVITY, DELAYED; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; SIALOGLYCOPROTEINS; TUBERCULIN; TUBERCULOSIS;

EID: 0033591633     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.12.1863     Document Type: Article

References (55)

1. Sreevastsan, S., X. Pan, K.E. Stockbauer, N.D. Connell, B.N. Kreiswirth, T.S. Whittam, and J.M. Musser. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA. 94:9869-9874.
2. Stead, W. 1992. Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering? Ann. Intern. Med. 116:937-941.
3. Sousa, A.O., J.I. Salem, F.K. Lee, M.C. Verçosa, P. Cruaud, B.R. Bloom, P.H. Lagrange, and H.L. David. 1997. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc. Natl. Acad. Sci. USA. 94:13227-13232.
4. Comstock, G.W. 1978. Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. Dis. 117:621-624.
5. Newport, M.J., C.M. Huxley, S. Huston, C.M. Hawrylowicz, B.A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
6. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J.F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, et al. 1996. Interferon-gamma-receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956-1961.
7. Dorman, S.E., and S.M. Holland. 1998. Mutation in the signal-transducing chain of the interferon γ receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101: 2364-2369.
8. Jong, R., F. Altare, I.A. Haagen, D.G. Elferink, T. Boer, P.J.C. van Breda Vriesman, P.J. Kabel, J.M.T. Draaisma, J.T. van Dissel, F.P. Kroon, et al. 1998. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science. 280:1435-1438.
9. Altare, F., A. Durandy, D. Lammas, J.F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 280:1432-1435.
10. Altare, F., D. Lammas, P. Revy, E. Jouanguy, R. Doffinger, S. Lamhamedi, P. Drysdale, D. Scheel-Toellner, J. Girdlestone, P. Darbyshire, et al. 1998. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis-disseminated infection. J. Clin. Invest. 102:2035-2040.
11. Bellamy, R., C. Ruwende, T. Corrah, K.P. McAdam, H.C. Whittle, and A.V. Hill. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338:640-644.
12. Bellamy, R., C. Ruwende, T. Corrah, K.P. McAdam, M. Thursz, H.C. Whittle, and A.V. Hill. 1999. Tuberculosis and chronic Hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 179:721-724.
13. Valway, S.E., M.P. Sanchez, T.F. Shinnick, I. Orme, T. Agerton, D. Hoy, J.S. Jones, H. Westmoreland, and I.M. Onorato. 1998. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338:633-639.
14. Hill, A.V. 1998. Immunogenetics of human infectious diseases. Annu. Rev. Immunol. 16:593-617.
15. Sugisaki, K., A.M. Dannenberg, Jr., Y. Abe, J. Tsuruta, W.J. Su, W. Said, L. Feng, T. Yoshimura, P.J. Converse, and P. Mounts. 1998. Nonspecific and immune-specific up-regulation of cytokines in rabbit dermal tuberculous (BCG) lesions. J. Leukoc. Biol. 63:440-450.
16. Kindler, V., A.P. Sappino, G.E. Grau, P.F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 56:731-740.
17. Arend, W.P., M. Malyak, C.J. Guthridge, and C. Gabay. 1998. Interleukin 1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16:27-55.
18. di Giovine, F.S., E. Takhsh, A.I.F. Blakemore, and G.W. Duff. 1993. Single base polymorphism at -511 in the human interleukin-1β gene. Hum. Mol. Genet. 1:450.
19. Pociot, F., J. Molvig, L. Wogensen, H. Worsaae, and J. Nerup. 1992. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22:396-402.
20. Tarlow, J.K., A.I.F. Blakemore, A. Lennard, R. Solari, H.N. Hughes, A. Steinkasserer, and G.W. Duff. 1993. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91:403-404.
21. Danis, V.A., M. Millington, V.J. Hyland, and D. Grennan. 1995. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99:303-310.
22. Hurme, M., and S. Santilla. 1998. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur. J. Immunol. 28:2598-2602.
23. Juffermans, N., A. Verbon, S. van Deventer, H. van Deutekom, P. Speelman, and T. van der Poll. 1998. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am. J. Respir. Crit. Care Med. 157: 1328-1331.
24. Akalm, H., A.C. Akdis, R. Mistik, S. Helvaci, and K. Kilicturgay. 1994. Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand. J. Infect. Dis. 26:667-674.
25. Ormerod, L., A. Charlett, C. Gilham, J. Darbyshire, and J. Watson. 1998. Geographical distribution of tuberculosis notifications in national surveys of England and Wales in 1988 and 1993: report of the public health laboratory service/ British Thoracic Society/Department of Health collaborative group. Thorax. 53:176-181.
26. Hirsch, C.S., T. Yoneda, L. Averill, J.J. Ellner, and Z. Toossi. 1994. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J. Infect. Dis. 170:1229-1237.
27. Toossi, Z., C.S. Hirsch, B.D. Hamilton, C.K. Knuth, M.A. Friedlander, and E.A. Rich. 1996. Decreased production of TGF-β1 by human alveolar macrophages compared with blood monocytes. J. Immunol. 156:3461-3468.
28. Arend, W.P. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54:167-227.
29. Hirsch, C.S., R. Hussain, Z. Toossi, G. Dawood, F. Shahid, and J.J. Ellner. 1996. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc. Natl. Acad. Sci. USA. 93:3193-3198.
30. Hirsch, C.S., J.J. Ellner, R. Blinkhorn, and Z. Toossi. 1997. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Prof. Natl. Acad. Sci. USA. 94:3926-3931.
31. Muzio, M., M. Sironi, N. Polentarutti, A. Mantovani, and F. Colotta. 1994. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur. J. Immunol. 24:3194-3198.
32. Jenkins, J.K., and W.P. Arend. 1993. Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF. Cytokines. 5:407-415.
33. Chizzolini, C., R. Chicheportiche, D. Burger, and J.M. Dayer. 1997. Human Th1 cells preferentially induce interleukin (IL)-1β while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur. J. Immunol. 27:171-177.
34. Barnes, P., S. Fong, P. Brennan, P. Twomey, A. Mazumder, and R. Modlin. 1990. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145: 149-154.
35. + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142:1114-1119.
36. Santtila, S., K. Savinainen, and M. Hurme. 1998. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand. J. Immunol. 47:195-198.
37. Denis, M., and E. Ghadirian. 1994. Interleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect. Immun. 62: 457-461.
38. Marshall, B.G., A. Wangoo, H.T. Cook, and R.J. Shaw. 1996. Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax. 51:1253-1261.
39. Zhang, Y., M. Broser, H. Cohen, M. Bodkin, K. Law, J. Reibman, and W.N. Rom. 1995. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95:586-592.
40. Gordon, S., S. Keshav, and M. Stein. 1994. BCG-induced granuloma formation in murine tissues. Immunobiology. 191:369-377.
41. Bergeron, A., M. Bonay, M. Kambouchner, D. Lecossier, M. Riquet, P. Soler, A. Hance, and A. Tazi. 1997. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159:3034-3043.
42. Agrewala, J.N., and R.J. Wilkinson. 1998. Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16 kDa α-crystallin antigen of Mycobacterium tuberculosis. Clin. Exp. Immunol. 104:392-397.
43. h2 profiles in tuberculosis based on proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 81:171-176.
44. Wilkinson, R.J., H.M. Vordermeier, K.A. Wilkinson, A. Sjölund, C. Moreno, G. Pasvol, and J. Ivanyi. 1998. Peptide specific response to M. tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 178:760-768.
45. Barnes, P., S. Lu, J. Abrams, E. Wang, M. Yamamura, and R. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489.
46. Johnson, C.M., A.M. Cooper, A.A. Frank, and I.M. Orme. 1998. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect. Immun. 66:1666-1670.
47. Bloom, B.R., and P.E.M. Fine. 1994. The BCG experience: implications for future vaccines against tuberculosis. In Tuberculosis: Pathogenesis, Protection and Control. B.R. Bloom, editor. American Society for Microbiology, Washington, DC. 531-557.
48. Sepulveda, R.L., I.M. Heiba, C. Navarrete, R.C. Elston, B. Gonzalez, and R.U. Sorensen. 1994. Tuberculin reactivity after newborn BCG immunisation in mono-and dizygotic twins. Tuber. Lung Dis. 75:138-143.
49. Sepulveda, R.L., I.M. Heiba, A. King, B. Gonzalez, R.C. Elston, and R.U. Sorensen. 1994. Evaluation for tuberculin reactivity in BCG immunised siblings. Am. J. Respir. Crit. Care Med. 149:620-624.
50. Abel, L., and A.J. Dessein. 1998. Genetic epidemiology of infectious diseases in humans: design of population based studies. Emerg. Infect. Dis. 4:593-603.
51. Bellamy, R., C. Ruwende, T. Corrah, K.P.W.J. McAdam, H.C. Whittle, and A.V. Hill. 1998. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuberc. Lung Dis. 79:83-90.
52. Daniel, T.M. 1997. Captain of Death: The Story of Tuberculosis. University of Rochester Press, Rochester, NY. 121-130.
53. Hirsch, E., V.M. Irikura, S.M. Paul, and D. Hirsh. 1996. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA. 93:11008-11013.
54. Horai, R., M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi, and Y. Iwakura. 1998. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187:1463-1475.
55. Akeson, A.L., C.W. Woods, L.C. Hsieh, R.A. Bohnke, B.L. Ackermann, K.Y. Chan, J.L. Robinson, S.D. Yanofsky, J.W. Jacobs, R.W. Barrett, et al. 1996. AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271:30517-30523.